Bridge City Capital’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
Other funds holding CORT
Bridge City Capital's CORT Position: Q3 2026 in Review
Bridge City Capital increased its Corcept Therapeutics (CORT) stake by 22% in Q3 2026, buying an estimated $1.26M and bringing the position to 65,530 shares worth $7.55M. The position accounts for 1.57% of the portfolio, ranked #23.
Bridge City Capital first reported a position in CORT in Q2 2020 and has held it in 26 quarters since. 500 funds tracked by Wall St. Rank hold CORT as of Q3 2026.
- Bridge City Capital held 65,530 shares of Corcept Therapeutics worth $7.55M as of Q3 2026.
- Bridge City Capital bought 11,707 Corcept Therapeutics shares in Q3 2026, an estimated $1.26M.
- Corcept Therapeutics made up 1.57% of Bridge City Capital's portfolio in Q3 2026, its #23 holding.
- Bridge City Capital first reported a position in Corcept Therapeutics in Q2 2020 and has held it in 26 quarters since.
- 500 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q3 2026.
Based on Bridge City Capital's 13F filing for Q3 2026, filed 29 Oct 2026.